Back
Aligos Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
ALGS
Aligos Therapeutics, Inc.
Last Price:
$7.00
Seasonality Move:
-25.49%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing slight buying pressure.
Aligos Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.98 | Buy |
| 20-day SMA: | 7 | Buy |
| 50-day SMA: | 7.95 | Sell |
| 200-day SMA: | 8.61 | Sell |
| 8-day EMA: | 6.95 | Buy |
| 20-day EMA: | 7.12 | Sell |
| 50-day EMA: | 7.78 | Sell |
| 200-day EMA: | 9.47 | Sell |
Aligos Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 46.07 | Sell |
| Chaikin Money Flow: | 9582 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.74 - 7.36) | Sell |
| Bollinger Bands (100): | (7.11 - 10.15) | Sell |
Aligos Therapeutics, Inc. Technical Analysis
| Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 24 | 25 | 26 | 27 | 02 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics, Inc. Stock
Is Aligos Therapeutics, Inc. Stock a Buy?
-
Aligos Therapeutics, Inc. share price is 7.03 while ALGS 8-day simple moving average is 6.98, which is a Buy signal.
-
The stock price of ALGS is 7.03 while Aligos Therapeutics, Inc. 20-day SMA is 7.00, which makes it a Buy.
-
Aligos Therapeutics, Inc. 50-day simple moving average is 7.95 while ALGS share price is 7.03, making it a Sell technically.
-
ALGS stock price is 7.03 and Aligos Therapeutics, Inc. 200-day simple moving average is 8.61, creating a Sell signal.
ALGS Technical Analysis vs Fundamental Analysis
Sell
27
Aligos Therapeutics, Inc. (ALGS)
is a Sell
Is Aligos Therapeutics, Inc. a Buy or a Sell?
-
Aligos Therapeutics, Inc. stock is rated a SellThe current Aligos Therapeutics, Inc. [ALGS] share price is $7.03. The Score for ALGS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Aligos Therapeutics, Inc. Stock Info
Market Cap:
43.7M
Price in USD:
7.03
Share Volume:
37.3K
Aligos Therapeutics, Inc. 52-Week Range
52-Week High:
13.69
52-Week Low:
3.76
Sell
27
Aligos Therapeutics, Inc. (ALGS)
is a Sell
Aligos Therapeutics, Inc. Share Price Forecast
-
What is the Aligos Therapeutics, Inc. stock price today?The Aligos Therapeutics, Inc. stock price is 7.03 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics, Inc. is overvalued.
Is Aligos Therapeutics, Inc. Stock a Buy?
-
Aligos Therapeutics, Inc. share price is 7.03 while ALGS 8-day exponential moving average is 6.95, which is a Buy signal.
-
The stock price of ALGS is 7.03 while Aligos Therapeutics, Inc. 20-day EMA is 7.12, which makes it a Sell.
-
Aligos Therapeutics, Inc. 50-day exponential moving average is 7.78 while ALGS share price is 7.03, making it a Sell technically.
-
ALGS stock price is 7.03 and Aligos Therapeutics, Inc. 200-day simple moving average is 9.47, creating a Sell signal.
Fundamental Analysis of Aligos Therapeutics, Inc.
Is Aligos Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.92 per share, and an increase next year of $0.49 per share.
Technical Analysis of Aligos Therapeutics, Inc.
Should I short Aligos Therapeutics, Inc. stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Aligos Therapeutics, Inc. is a Sell
-
Aligos Therapeutics, Inc. Relative Strength Index (RSI) is 46.07, which suggest Aligos Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Aligos Therapeutics, Inc. is (6.74 - 7.36), which suggest Aligos Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Aligos Therapeutics, Inc. is (7.11 - 10.15), which suggest Aligos Therapeutics, Inc. is a Sell
* Aligos Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.